Angiogenic molecular signature in colorectal cancer: Pharmacogenomic implications for the use of antiangiogenic therapies
In the framework of personalized medicine in antiangiogenesis, we took a translational research approach to explore the angiogenic molecular signature of advanced CRC patients. As derived from our findings in vitro, the tumour microenvironment of CRC metastases would be different to that of primar...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | info:eu-repo/semantics/doctoralThesis |
| Kieli: | eng |
| Julkaistu: |
Servicio de Publicaciones de la Universidad de Navarra
2014
|
| Aiheet: | |
| Linkit: | https://hdl.handle.net/10171/36697 |